1. |
Moe S, Drüeke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2006, 69(11): 1945-1953.
|
2. |
Kim WS, Lee DH, Youn HJ. Calcium-phosphorus product concentration is a risk factor of coronary artery disease in metabolic syndrome. Atherosclerosis, 2013, 229(1): 253-257.
|
3. |
Wang Y, Xie G, Huang Y, et al. Calcium acetate or Calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis. PLoS One, 2015, 10(3): 1376-1377.
|
4. |
杨晓晓, 姜娜, 黄佳颖, 等. 腹膜透析患者高磷血症的相关因素分析. 中华肾脏病杂志, 2014, 30(1): 29-34.
|
5. |
Bousher A, Al-Makki A, Sutton J, et al. A review of sucroferric oxyhydroxide for the treatment of hyperphosphatemia in patients receiving dialysis. Clin Ther, 2014, 36(12): 2082-2093.
|
6. |
Komaba H, Kakuta T, Suzuki H, et al. Survival advantage of lanthanum carbonate for hemodialysis patients with uncontrolled hyperphosphatemia. Nephrol Dial Transplant, 2015, 30(1): 107-114.
|
7. |
Yokoyama K, Akiba T, Fukagawa M, et al. JTT-751 for treatment of patients with hyperphosphatemia on peritoneal dialysis. Nephron Clin Pract, 2014, 128(1/2): 135-140.
|
8. |
Shin S, Lee S. Niacin as a drug repositioning candidate for hyperphosphatemia management in dialysis patients. Ther Clin Risk Manag, 2014, 10(10): 875-883.
|
9. |
蒲超, 陈永忠, 白佳柠, 等. 三种不同血液净化方式对维持性血液透析患者高磷血症清除的临床研究. 华西医学, 2013, 28(4): 495-598.
|
10. |
Winchester JF, Rotellar C, Goggins M, et al. Calcium and phosphate balance in dialysis patients. Kidney Int, 1993, 41(Suppl 41): S174-S178.
|
11. |
Takahara Y, Matsuda Y, Takahashi S, et al. Efficacy and safety of lanthanum carbonate in pre-dialysis CKD patients with hyperphosphatemia: a randomized trial. Clin Nephrol, 2014, 82(3): 181-190.
|
12. |
Streja E, Lau WL, Goldstein L, et al. Hyperphosphatemia is a combined function of high serum PTH and high dietary protein intake in dialysis patients. Kidney Int Suppl, 2013, 3(5): 462-468.
|
13. |
Karavetian M, de Vries N, Rizk R, et al. Dietary educational interventions for management of hyperphosphatemia in hemodialysis patients: a systematic review and meta-analysis. Nutr Rev, 2014, 72(7): 471-482.
|
14. |
Locatelli F, Del Vecchio L, Violo L, et al. Phosphate binders for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis: a comparison of safety profiles. Expert Opin Drug Saf, 2014, 13(5): 551-561.
|
15. |
Huang W, Liu J, Tang Y, et al. Efficacy and tolerability of lanthanum carbonate in treatment of hyperphosphatemia patients receiving dialysis--a systematic review and meta-analysis of randomized controlled trials. Curr Med Res Opin, 2014, 30(1): 99-108.
|